NYU Langone

 

NYU Langone
B

How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease with Low Mortality: Shaped by 50 Years of Clinical Research and Practice

By NYU Langone FEATURING Barry Maron
By NYU Langone FEATURING Barry Maron
26 views
February 22, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Management Decisions in Hypertrophic Cardiomyopathy
20:37

Apical-Mid and Mid-LV HCM Surgery: Technical Pearls

NYU Langone

H. Schaff

27 views
31:10

How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Gene…

NYU Langone

B. Maron

26 views
25:30

Disopyramide, Cibenzoline and Escibenzoline for OCHM

NYU Langone

M. Sherrid

385 views
18:42

SUB-Q vs. Transvenous ICD for Sudden Cardiac Death Prevention: Why a…

NYU Langone

L. Jankelson

362 views